Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-13
DOI
10.1186/s13046-019-1514-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer
- (2018) Heng Zhang et al. ANNALS OF SURGERY
- Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression
- (2018) Jian Chen et al. CANCER LETTERS
- Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis
- (2018) Zehong Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer
- (2018) Liang Yu et al. CLINICAL CANCER RESEARCH
- External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China
- (2018) Jinning Ye et al. SURGICAL ONCOLOGY-OXFORD
- Cobra Venom Factor-induced complement depletion protects against lung ischemia reperfusion injury through alleviating blood-air barrier damage
- (2018) Chang Haihua et al. Scientific Reports
- Asparaginyl Endopeptidase (Legumain) Supports Human Th1 Induction via Cathepsin L-Mediated Intracellular C3 Activation
- (2018) Simon Freeley et al. Frontiers in Immunology
- The complement system in cancer: Ambivalence between tumour destruction and promotion
- (2017) Srinivas Mamidi et al. IMMUNOBIOLOGY
- The renaissance of complement therapeutics
- (2017) Daniel Ricklin et al. Nature Reviews Nephrology
- Linc00152 promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung adenocarcinoma
- (2017) Pei-pei Zhang et al. Journal of Cancer
- Innate immune mediators in cancer: between defense and resistance
- (2016) Pedro Berraondo et al. IMMUNOLOGICAL REVIEWS
- C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
- (2016) Roberta Bulla et al. Nature Communications
- Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer
- (2015) Stephanie Downs-Canner et al. ANNALS OF SURGICAL ONCOLOGY
- From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis
- (2015) Timo Rath et al. ARCHIVES OF TOXICOLOGY
- PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
- (2015) Eduardo Bonavita et al. CELL
- The prognostic value of pSTAT3 in gastric cancer: a meta-analysis
- (2015) S. Yu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
- (2014) S. K. Vadrevu et al. CANCER RESEARCH
- Interleukin 22 protects colorectal cancer cells from chemotherapy by activating the STAT3 pathway and inducing autocrine expression of interleukin 8
- (2014) Tingyu Wu et al. CLINICAL IMMUNOLOGY
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Genetics of gastric cancer
- (2014) Mairi H. McLean et al. Nature Reviews Gastroenterology & Hepatology
- Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
- (2014) Cecília Durães et al. VIRCHOWS ARCHIV
- Autocrine Effects of Tumor-Derived Complement
- (2014) Min Soon Cho et al. Cell Reports
- Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer
- (2013) Daniel Ajona et al. JNCI-Journal of the National Cancer Institute
- Gastric cancer—molecular and clinical dimensions
- (2013) Roopma Wadhwa et al. Nature Reviews Clinical Oncology
- Complement inhibition in cancer therapy
- (2013) Ruben Pio et al. SEMINARS IN IMMUNOLOGY
- MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3
- (2011) Bing Feng et al. CANCER
- Synthesis of the third component of complement (C3) by human gastric cancer-derived cell lines
- (2010) E. KITANO et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cancer and the Complement Cascade
- (2010) M. J. Rutkowski et al. MOLECULAR CANCER RESEARCH
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search